GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Tatva Chintan Pharma Chem Ltd (BOM:543321) » Definitions » PEG Ratio

Tatva Chintan Pharma Chem (BOM:543321) PEG Ratio : 7.16 (As of May. 26, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Tatva Chintan Pharma Chem PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Tatva Chintan Pharma Chem's PE Ratio without NRI is 82.34. Tatva Chintan Pharma Chem's 5-Year EBITDA growth rate is 11.50%. Therefore, Tatva Chintan Pharma Chem's PEG Ratio for today is 7.16.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Tatva Chintan Pharma Chem's PEG Ratio or its related term are showing as below:

BOM:543321' s PEG Ratio Range Over the Past 10 Years
Min: 7.1   Med: 8.1   Max: 8.39
Current: 7.16


During the past 6 years, Tatva Chintan Pharma Chem's highest PEG Ratio was 8.39. The lowest was 7.10. And the median was 8.10.


BOM:543321's PEG Ratio is ranked worse than
82.3% of 712 companies
in the Chemicals industry
Industry Median: 1.92 vs BOM:543321: 7.16

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Tatva Chintan Pharma Chem PEG Ratio Historical Data

The historical data trend for Tatva Chintan Pharma Chem's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tatva Chintan Pharma Chem PEG Ratio Chart

Tatva Chintan Pharma Chem Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
PEG Ratio
Get a 7-Day Free Trial - - - - 7.09

Tatva Chintan Pharma Chem Quarterly Data
Mar19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 7.09

Competitive Comparison of Tatva Chintan Pharma Chem's PEG Ratio

For the Specialty Chemicals subindustry, Tatva Chintan Pharma Chem's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tatva Chintan Pharma Chem's PEG Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Tatva Chintan Pharma Chem's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Tatva Chintan Pharma Chem's PEG Ratio falls into.



Tatva Chintan Pharma Chem PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Tatva Chintan Pharma Chem's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=82.344336084021/11.50
=7.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Tatva Chintan Pharma Chem  (BOM:543321) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Tatva Chintan Pharma Chem PEG Ratio Related Terms

Thank you for viewing the detailed overview of Tatva Chintan Pharma Chem's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Tatva Chintan Pharma Chem (BOM:543321) Business Description

Traded in Other Exchanges
Address
Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.

Tatva Chintan Pharma Chem (BOM:543321) Headlines

No Headlines